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Echocardiogr 2009;10:745–52.REPLY: Longitudinal Strain and Type 1
Diabetes Mellitus: Are We on the
Wrong Track?We thank Drs. Tadic and Cuspidi for their interest in
our paper (1). Drs. Tadic and Cuspidi comment that
global longitudinal strain (GLS) in the present study
is somewhat lower than expected for a healthy
middle-aged population; for example, like in the
reports of Kocabay et al. (2) and Yingchocharoen et
al. (3). First, the reason for including a control
population in the present study is precisely to
compare results with a healthy, normal population,
rather than with estimates from the published
reports, knowing that absolute GLS values differ
between reports. Second, the Kocabay et al. (2) study
included 247 subjects, and the meta-analysis from
Yingchocharoen et al. (3) reported GLS estimates
compiled from 28 different studies with a total of
2,597 individuals; in that study, individual study
populations ranged from 13 individuals to 673
individuals. In comparison, the present population of
1,263 individuals (1,065 patients with type 1 diabetes
mellitus [T1DM] and 198 control subjects) is almost
one-half the size of the total participant number in
the meta-analysis where reported mean GLS values
were between –15.9% and –22.1%. We report that the
control subjects have a mean GLS of –18.8% and
T1DM patients a GLS of –18.3%, which we ﬁnd to be
reasonable and within expected limits.Also, Drs. Tadic and Cuspidi discuss whether or
not medical therapy in T1DM can improve left ven-
tricular structure and function, and they reference a
series of randomized controlled trials on this sub-
ject. The present cross-sectional study was not
designed to address this matter, but we would sus-
pect that cardiac function would be worse in pa-
tients from the Thousand & 1 Study had they not
received cardioprotective and renoprotective medi-
cations via their usual clinical control at the outpa-
tient clinic at Steno Diabetes Center. Drs. Tadic and
Cuspidi further suggest investigating the association
between medication and LV structure and function
in T1DM more closely. We are thankful for this
suggestion and look forward to doing this in future
studies.Magnus Thorsten Jensen, MD, PhD*
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